As per attachment

GlaxoSmithKline Pharmaceuticals Limited GSK House, Dr. Annie Besant Road, Worli, Mumbai - 400 030 Tel No: +91 22 2495 9595 Fax No: +91 22 2495 9494 Web: www.gsk-india.com Email: askus@gsk.com 4th August 2026 BSE LIMITED THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, G Block Dalal Street Bandra-Kurla Complex, Bandra (East) Mumbai - 400001 Mumbai - 400051 Dear Sir, Sub: Advertisement relating to Financial Results Pursuant to clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), we enclose advertisements given in Economic Times, Business Standard and Maharashtra Times relating publication of Unaudited Financial Results for quarter ended 30th June 2026. Thanking you, Yours faithfully For GlaxoSmithKline Pharmaceuticals Limited Ajay Nadkarni Vice President – Administration, Real Estate & Company Secretary Encl: Public Notice CIN: L24239MH1924PLC001151 RegisteredOffice:GSKHouse,Dr.AnnieBesantRoad,Worli,Mumbai400030•Website:https://india-pharma.gsk.com/en-in/ Telephone:022-24959595•Email:in.investorquery@gsk.com•CorporateIdentityNumber:L24239MH1924PLC001151 STATEMENTOFSTANDALONEANDCONSOLIDATEDUNAUDITEDFINANCIALRESULTSFORTHEQUARTERENDED30THJUNE,2026 (`inLakhs) Standalone Consolidated (Unaudited) (Unaudited) (Unaudited) (Audited) (Unaudited) (Unaudited) (Unaudited) (Audited) Particulars Preceding Preceding 3months Corresponding 3months Corresponding 3months Yearended 3months Yearended ended 3monthsended ended 3monthsended ended 31.03.2026 ended 31.03.2026 30.06.2026 30.06.2025 30.06.2026 30.06.2025 31.03.2026 31.03.2026 1 Revenuefromoperations 92442 98915 80483 379020 93844 99530 80517 382167 2 ProfitbeforeExceptionalItemsandtax 33798 36912 27857 137359 32245 37310 27898 138539 3 ExceptionalItems(credit) – – – 264 – – – 2062 4 Profitbeforetax 33798 36912 27857 137623 32245 37310 27898 140601 5 NetProfitaftertax 25333 27494 20470 101182 23718 27786 20501 103598 6 Totalcomprehensiveincomefortheperiod 25333 26120 20470 100428 23718 26412 20501 102844 7 Paid-upEquityShareCapital 16941 16941 16941 16941 16941 16941 16941 16941 (Facevaluepershare`10) 8 OtherEquity – – – 207177 – – – 209801 9 EarningsPerShare(EPS)(of`10each) BasicanddilutedEPSbeforeExceptionalItems(`) 14.95 16.23 12.08 59.59 14.00 16.40 12.10 60.11 BasicanddilutedEPSafterExceptionalItems(`) 14.95 16.23 12.08 59.73 14.00 16.40 12.10 61.15 NotAnnualised NotAnnualised Notes: 1.TheaboveisanextractofthedetailedformatoftheFinancialResultsforthequarterendedJune30,2026filedwiththeStockExchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The full format of the said Financial ResultsareavailableonthewebsiteoftheCompanyatwww.india-pharma.gsk.comandonthewebsiteofStockExchangesatwww.nseindia.com andwww.bseindia.com. 2.TheaboveResultswerereviewedbytheAuditCommitteeandwerethereafterapprovedbytheBoardofDirectorsattheirrespectivemeetingsheld on3rdAugust,2026. ByOrderoftheBoard BhushanAkshikar Place:Mumbai ManagingDirector Date:3rdAugust,2026 DIN:09112346 Notice–cum–AddendumtotheSchemeInformationDocument/KeyInformationMemorandum /StatementofAdditionalInformationtotheschemesofSundaramMutualFund(‘Fund’) AppointmentofKeyPersonnelofAMC NoticeisherebygiventhatMr.RonakShahhasbeenappointedastheAssociateFundManager–FixedIncome,effectiveAugust 03,2026.Accordingly,hisdetailsshallbeaddedunder‘InformationonKeyPersonnel’intheStatementofAdditionalInformation (“SAI”)oftheSundaramMutualFund. Name&Designation Age/Educational BriefExperience Qualifications Mr.RonakShah Age:-37years 13+yearsofexperienceinFixedIncomeInvestmentsandFundManagement AssociateFundManager– EducationalQualification: • May2017toJuly2026– FixedIncome MBA,B.Com TataAIALifeInsuranceCo.Ltd.–Investments(DealinginFixedIncomeSecuritiesand FundManagement) • Dec2012toApr2017– DeriviumTraditionandSecurities(P)Ltd.–Broking(DealinginFixedIncomeSecurities) All other terms and conditions of the Scheme Information Document(s) / Key Information Memorandum(s) / Statement of AdditionalInformationwillremainunchanged. ThisaddendumformsanintegralpartoftheSchemeInformationDocument(SID)/KeyInformationMemorandum(KIM)/ StatementofAdditionalInformation(SAI)oftheschemesofSundaramMutualFundasamendedfromtimetotime. ForSundaramAssetManagementCompanyLtd Place:Chennai RAjithKumar Date:August04,2026 CompanySecretary&ComplianceOfficer Formoreinformationpleasecontact: CorporateOffice: 1st&2ndFloor,SundaramTowers,46,WhitesRoad, Royapettah,Chennai-14. SundaramAssetManagementCompanyLtd ContactNo.(India)18604257237,(NRI)+914023452215 (InvestmentManagertoSundaramMutualFund) www.sundarammutual.com CIN:U93090TN1996PLC034615 Regd.Office: No.21,PatullosRoad,Chennai600002. MutualFundInvestmentsaresubjecttomarketrisks,readallschemerelateddocumentscarefully. )smc11x61(31-1-72-62-1YH 14 B MUMBAI | TUESDAY,4AUGUST2026 bbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb TBO Tek Limited RegisteredOffice:UnitNo.501,5thFloor,Worldmark-4,AssetAreaNo.LP-IB-04, Aerocity,NearIndiraGandhiInternationalAirport,NewDelhi–110037 Corp.Office:PlotNo.728,UdyogViharPhase-V,Gurugram-122016,Haryana,India CIN:L74999DL2006PLC155233,Website:www.tbo.com Email:corporatesecretarial@tbo.com,Tel.:+911244998999 INFORMATIONREGARDINGTHE20THANNUALGENERALMEETINGTOBE HELDTHROUGHVIDEOCONFERENCING/OTHERAUDIO-VISUALMEANS The members of the TBO Tek Limited (‘Company’) are hereby informed that Twentieth(20th)AnnualGeneralMeeting(‘AGM’)oftheCompanyisscheduledto beheldonThursday,August27,2026at12:00Noon(IST)onwardsthroughVideo Conference(‘VC’)/OtherAudio-VisualMeans(‘OAVM’)totransactthebusinesses thatwillbesetforthinthenoticeofthe20thAGM(‘Notice’). TheMinistryofCorporateAffairs(‘MCA’)videitsGeneralCircularNos.14/2020 datedApril08,2020,17/2020datedApril13,2020,20/2020datedMay05,2020 andsubsequentcircularsissuedinthisregard,latestbeingGeneralCircularNo. 03/2025datedSeptember22,2025('MCACirculars')haspermittedtheholding ofAGM throughVC/OAVM. In compliancewith the MCACirculars,the relevant provisionsoftheCompaniesAct,2013(‘Act’),readwithRulesmadethereunder and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘ListingRegulations’),the20thAGMoftheCompanywillbeheldthroughVC/OAVM, withoutthephysicalpresenceofthemembersatacommonvenue. In accordance with Listing Regulations and MCA Circulars, the Notice and AnnualReportfortheFinancialYear2025-26(‘AnnualReport’)willbesent,in due course, by electronic mode to those members whose email addresses are registered with the Company/its registrar and share transfer agent (‘RTA’), i.e. KFin Technologies Limited or with respective Depository Participants ('DPs'). TheNoticeandAnnualReportwillalsobeavailableontheCompany'swebsiteat www.tbo.com,onthewebsitesofthestockexchanges,i.e.NationalStockExchange ofIndiaLimitedatwww.nseindia.comandBSELimitedatwww.bseindia.comandon thewebsiteofNationalSecuritiesDepositoryLimited(‘NSDL’)atwww.nsdlindia.com. IncompliancewithRegulation36(1)(b)oftheListingRegulations,aletterproviding theweblink,includingtheexactpathforaccessingtheNoticeandAnnualReport willbesenttothosememberswhohavenotregisteredtheiremailaddresseswith Company/RTA/DPs. IncasethemembersaredesirousofobtainingahardcopyoftheNoticeandAnnual Report,theymaysendtherequesttotheCompanyatcorporatesecretarial@tbo.com mentioningtheirFolioNo./DPIDandClientID. The instructions for joiningand mannerof participation in the 20thAGM willbe providedintheNotice.Themembersattendingthe20thAGMthroughVC/OAVMwill becountedforthepurposeofreckoningthequorumunderSection103oftheAct. Mannerofcastingvote(s)throughelectronicmode TheCompanyisprovidingthefacilityforremoteE-votingandE-votingduringthe AGM,enablingmemberstocasttheirvotesonalltheresolutionsassetoutinthe Notice. Thedetailedprocedure,requ [Showing first 8,000 characters — download PDF for full document]